Senate Once Again Tries to Address Drug Pricing | McDonnell Boehnen Hulbert & Berghoff LLP

Over the past several years Congress has tried to address high drug prices, with variable success  (see "FTC to the Rescue Regarding High Drug Prices and Patents"; "Even More...

Related Keywords

United States ,John Hickenlooper ,Margaret Wood Hassan ,Michael Bennet ,Human Services ,Innovative Research Drug Pricing ,Congress Regarding Prescription Drug ,Youtube ,Public Health Service ,Catalyst Pharms Inc ,Drug Administration ,Us Senate Health ,Rescue Regarding High Drug Prices ,More Ill Conceived Remedies ,Ill Conceived Remedies ,Executive Orders ,Inflation Reduction Act ,Ensuring Timely Access ,Generics Act ,Expanding Access ,Low Cost Generics Act ,Retaining Access ,Restoring Exclusivity Act ,Increasing Transparency ,Generic Drug Applications Act ,Jeanne Shaheen ,Susan Collins ,Marco Rubio ,Tammy Baldwin ,Mike Braun ,Cosmetic Act ,Public Health Service Act ,Federal Trade Commission ,Citizen Petition ,Senator Collins ,Tina Smith ,Restoring Exclusivity ,Catalyst Pharms ,Rand Paul ,Fair Accountability ,Innovative Research Drug Pricing Act ,Annual Report ,